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Abstract
Introduction Thrombus density may be a predictor for acute
ischemic stroke treatment success. However, only limited data
on observer variability for thrombus density measurements
exist. This study assesses the variability and bias of four com-
mon thrombus density measurement methods by expert and
non-expert observers.
Methods For 132 consecutive patients with acute ischemic
stroke, three experts and two trained observers determined
thrombus density by placing three standardized regions of
interest (ROIs) in the thrombus and corresponding contralat-
eral arterial segment. Subsequently, absolute and relative
thrombus densities were determined using either one or three
ROIs. Intraclass correlation coefficient (ICC) was determined,
and Bland–Altman analysis was performed to evaluate inter-
observer and intermethod agreement. Accuracy of the trained
observer was evaluated with a reference expert observer using
the same statistical analysis.
Results The highest interobserver agreement was obtained for
absolute thrombus measurements using three ROIs (ICCs
ranging from 0.54 to 0.91). In general, interobserver agree-
ment was lower for relative measurements, and for using one
instead of three ROIs. Interobserver agreement of trained non-
experts and experts was similar. Accuracy of the trained ob-
server measurements was comparable to the expert interob-
server agreement and was better for absolute measurements
and with three ROIs. The agreement between the one ROI and
three ROI methods was good.
Conclusion Absolute thrombus density measurement has supe-
rior interobserver agreement compared to relative density mea-
surement. Interobserver variation is smaller whenmultiple ROIs
are used. Trained non-expert observers can accurately and re-
producibly assess absolute thrombus densities using three ROIs.
Keywords Brain ischemia . Thromboembolism . Computed
tomography . X-ray . Observer agreements
Abbreviations
ICC Intraclass correlation coefficients
aHU Absolute thrombus density in Hounsfield unit
rHU Relative thrombus density
HU Hounsfield unit
LoA Limits of Agreement
SD Standard deviation
Introduction
In acute ischemic stroke, imaging provides information that is
crucial to proper patient selection for emergent treatments,
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including the presence and level of vessel occlusion and the
extent of irreversible tissue injury [1]. More recently, throm-
bus density on non-contrast CT (NCCT) has been shown to be
a potential predictor for acute ischemic stroke treatment suc-
cess [2–5]. Clot density is usually assessed by gross visual
inspection (e.g., hyperdense artery sign). Quantitative assess-
ment of thrombus density can be performed by placing one or
multiple small regions of interest (ROIs) in the thrombus—for
example, using measuring tools available on diagnostic work-
stations to create ROIs of specific size and shape [5, 6]. Be-
cause thrombus density measurements are affected by hemat-
ocrit, some groups have measured the density in the corre-
sponding contralateral vessel to calculate a relative density
[7]. Four methods have been employed in the recent literature:
absolute thrombus density in Hounsfield unit (aHU) and rela-
tive thrombus density in Hounsfield unit (rHU) using either
one or three ROIs. Little is known regarding the interobserver
agreement of these measurements. Furthermore, the impact of
expertise and the bias due to using one ROI instead of three
ROIs have not been studied.
Our goals were to examine the interobserver agreement of
both experts and non-experts for the four common thrombus
density measurement methods, and to evaluate the possible
bias introduced by using one rather than multiple ROIs.
Methods
Patient selection
We collected image data from the Dutch MR CLEAN clinical
trial, a multicenter randomized controlled trial that evaluated
whether intraarterial treatment of patients with acute ischemic
stroke improved functional outcome at 3 months [8]. The
main criterion for study inclusion was concurrent thin-slice
(≤2.5 mm) NCCT and CT angiography (CTA) image data.
As it can be difficult to detect low-density thrombi on NCCT,
and standardized CTA imaging is increasingly used as part of
standard admission protocol for patients suspected of acute
stroke [1], CTA is commonly used for visual support in most
thrombus density studies [3–5, 9–11]. In some studies, it was
reported that CTA and NCCT were registered for the assess-
ment of the clot burden [12]. We consequently, also used CTA
for visual support to localize thrombi. Furthermore, we man-
dated that the time interval between these scans be a maxi-
mum of 30 min because possible IV thrombolysis initiated
directly after NCCT acquisition may cause thrombus alter-
ation or migration [1].We retrospectively collected image data
from 388 available patients at the time of this study, of which
204 patients had both thin-slice NCCT and CTA image data.
We excluded patients due to time delay between modalities
greater than 30 min (N=13), movement artifacts (N=39), ex-
tensive noise (N=5), incomplete coverage of the intracranial
arteries (N=4), and major differences in thrombus location
between the two image modalities (N=2). Out of the remain-
ing 141 patients, 9 were included in the training set, and the
other 132 constituted the test set. A table with detailed infor-
mation about the scanners, CT parameters, and reconstruc-
tions parameters can be found in the Online Resource 1.
Thrombus density measurement
Thrombus measurements can be performed in any radiologi-
cal workstation [3]. This task consists of detecting the throm-
bus in NCCT images and measuring its density by the place-
ment standardized measurement tools (e.g., ROIs such as 2D
ellipses or 3D spheres); see Fig. 1. As a support for the detec-
tion of low-density thrombi, CTA images can be displayed
simultaneously with the NCCT images. For the simultaneous
displaying of NCCT and CTA images, CTA images were au-
tomatically aligned with NCCT images using a rigid registra-
tion of the open source software Elastix® [13]. In this study,
we performed the annotations and measurements with in
Mevislab® developed software [14]. Thrombus density was
measured in the proximal, middle, and distal part using three
separate spherical volumes with a radius of 1 mm. In case of
NCCT
CTA
Fig. 1 Illustration of the thrombus and contralateral ROI placements on
registered NCCT (top) and CTA (bottom). The white arrows are
indicating the locations of the thrombus ROIs (blue spheres) and the
contralateral ROIs (green spheres)
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small thrombi, the ROIs often overlapped, which was accept-
ed in our study. Our method assured that in case of overlap-
ping ROIs, the attenuation values of every pixel were counted
only once. In a similar fashion, contralateral density measures
were performed at the corresponding site of occlusion [3]. The
middle ROI density measurement of both the thrombus and
contralateral artery was used for the single ROI measurement.
Based on the CT attenuation values, the average absolute
thrombus density in Hounsfield units (aHU) and average rel-
ative thrombus density in Hounsfield units (rHU) for three and
one ROIs, abbreviated as aHU3, rHU3, aHU1, and rHU1,
respectively, were determined.
Three expert neuroradiologists each with more than
10 years of experience (AY, LB, CM) and two non-expert
trained observers (MB and CW, one with a MSc in Biomed-
ical Engineering and a fifth-year student in MSc Technical
Medicine) placed the ROIs. The trained observers received
approximately 3 h of training. The observers only had access
to baseline NCCT and CTA images during the measurement
sessions and were blinded frommeasured intensity, all clinical
information, and each other’s measurements.
Before the measurements, a calibration session was orga-
nized in which the observers performed the measurement in a
training set of nine randomly selected datasets. This calibra-
tion session was used to assess any differences in interpreta-
tion and measurement strategy. Differences were discussed in
a subsequent consensus meeting, after which the following
additional instruction was provided; in case of thrombus at a
bifurcation, only the longest branch should be used for the
measurement.
During the measurements, the observers could exclude a
dataset if the image quality was considered insufficient to
confidently place the ROIs, or if the occlusion was not distin-
guishable. If a dataset was excluded, the reason was recorded.
After the measurements, a verification of the number of
markers as well as a visual check of all ROIs was performed
by a single external observer (ES) to detect missing, supernu-
merary, or incorrectly labeled ROI. These suspicious ROIs
were discussed and corrected by the same observer if neces-
sary. The number of incorrect ROI placements and performed
corrections was recorded.
Statistical analysis
The interobserver agreement of the thrombus density mea-
surements was evaluated by performing a paired comparison
of the measurements of observers 1 and 2 and of observers 1
and 3. The accuracy of the trained non-expert observers was
assessed by comparing measurements of observers 4 and 5
with that of observer 1 as the reference standard. The interob-
server agreement of the trained non-expert observers was
assessed by comparing measurements of observer 4 and ob-
server 5. For all comparisons, Bland–Altman analysis was
performed and the intraclass correlation coefficient (ICC)
was calculated.
To estimate the bias introduced by using only one instead
of three ROIs, we evaluated the intermethod agreement by
comparing the single ROI measurements with the three ROI
measurements, using the latter as reference. Statistical signif-
icance of the differences between one and three ROI measure-
ments was tested using paired t tests for normally distributed
data or a related-sample Wilcoxon signed-rank test otherwise.
Furthermore, a Bland–Altman analysis was performed and the
ICC was determined.
An ICC superior to 0.80 was considered as excellent, be-
tween 0.60 and 0.79 as good, between 0.40 and 0.59 as fair,
and below 0.39 as poor. Normality of the distributions was
tested using the Shapiro–Wilk test. Significance level was set
to a p value of 0.05. To identify outliers prior to the ICC
calculations, we used Tukey’s hinges method [15], in which
observations below Q1−1.5 (Q3−Q1) and above Q3+1.5(Q3
−Q1) were excluded. All analyses were performed using IBM
SPSS Statistics software, version 20.0 (IBM Corporation,
Armonk, NY, USA).
Results
The average age was 66 (±13) years and 62.1 % (82) of the
patients were male. For some patients, the measurements
could not be performed. Three observers excluded the dataset
of one patient and two observers excluded two datasets of two
patients because of insufficient contrast for accurate assess-
ment; one (expert) observer did not identify an occlusion for
one patient, and one (trained) observer could not detect an
occlusion in three patients. A total of 55 out of 522 annota-
tions (11 %) required a correction during follow-up sessions.
Forty-four (8.5 %) out of 522 measures were outliers,
consisting of 14 absolute and 30 relative densities. These were
excluded in the calculation of the ICCs.
The interobserver agreement for absolute density was good
to excellent for the two expert observer pairs with ICCs of 0.81
and 0.91 using three ROIs and 0.47 and 0.74 using one ROI.
For relative density, the agreement was poor to good with ICCs
of 0.25 and 0.74 for using three ROIs and 0.31 and 0.66 for
using one ROI. The width of the limits of agreement for abso-
lute density was smaller using three ROIs than for one ROI
(Online Resource 2); the same pattern can be observed for
relative density measurements (Online Resource 3).
The agreement of the trained observers with the reference
expert observer was good for absolute density measurements
with ICCs of 0.71 and 0.79 when using three markers. For a
single measurement, the agreement was somewhat lower with
ICCs of 0.37 and 0.71. The agreement was poor and fair for
relative densities with ICCs ranging between 0.15 and 0.50.
Similar to the expert observers, the interobserver agreement is
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better for the absolute measurement using three markers, with
an ICC of 0.71, which was comparable to the expert interob-
server agreement. The results of all Bland and Altman analysis
and ICC calculations are shown in Table 1. The Bland–Alt-
man graphs are shown in the Online Resource 2 and Online
Resource 3 for absolute and relative measures, respectively.
The intermethod agreement of the measurements with one
ROI compared to the three ROIs was excellent with an ICC of
0.84 for absolute and good with an ICC of 0.69 for relative
density measurements. The Bland and Altman graphs are
shown in Online Resource 4.
Discussion
Our study shows that interobserver agreement in thrombus
density measurements varies considerably from excellent to
poor depending on the method used. Agreement was higher
for absolute than for relative density measurements and higher
for using three ROIs compared to using one ROI.
The interobserver agreement of the absolute thrombus den-
sity measurements by the expert observers is in line with pre-
viously reported values [4]. Another study reported a similar
reliability for an intraobserver evaluation [3]. Despite the fact
that relative density measurements are being used in studies
[3, 4], no data on interobserver agreement were previously
reported. In most studies, three markers are used [3, 6], a
method supported by our analysis, whereas in one study, the
number of ROIs was not reported [4]. As shown in our study,
density measurement can be prone to errors as a moderate
amount of measurements required addition removal or adjust-
ment of a ROI after the inaccuracies were pointed out by an
external observer. None of these adjustments have previously
been reported in the literature.
The larger variation for relative density measurements sug-
gests that placement of ROIs in the contralateral vessel is less
robust than ROI placement in the thrombus. The relative den-
sity measurements have been introduced to correct for the
hematocrit. However, our findings suggest that this advantage
may potentially be negated by the increased variability of
thrombus measurement [3, 4].
Table 1 Bland–Altman analysis and the ICC calculations of the
interobserver agreement between expert observers (observers 1 and 2
and observers 1 and 3), interobserver agreement of trained observers
(observers 4 and 5), and comparison of the trained observers (4 and 5)
with the reference measurements of observer 1
ICC n (ICCs) Mean differences Upper–lower LoA
Expert observers Observer 1 and 2 (n=71) aHU3 0.90* 70 0.1 7.1–6.8
aHU1 0.74* 68 −0.7 10.3–11.7
rHU3 0.72* 66 −0.10 0.48 - 0.64
rHU1 0.66* 65 −0.09* 0.46–0.63
Observer 1 and 3 (n=61) aHU3 0.54* 61 5.8* 16.1–4.5
aHU1 0.47* 60 4.9* 21.0–11.2
rHU3 0.25* 60 0.07 0.64–0.49
rHU1 0.31* 58 0.04 0.75–0.66
Trained observers Observer 4 and 5 (n=127) aHU3 0.70* 123 −1.6 12.3–16.0
aHU1 0.40* 126 1.2 16.8–14.4
rHU3 0.48* 123 −0.01 0.56–0.60
rHU1 0.24* 117 0.01 1.00–0.97
Reference observer with trained observers Observer 1 and 4 (n=129) aHU3 0.79* 127 1.4* 10.4–7.6
aHU1 0.71* 127 1.1 13.3–11.2
rHU3 0.50* 126 0.03 0.49–0.43
rHU1 0.46* 120 0.00 0.67–0.68
Observer 1 and 5 (n=127) aHU3 0.71* 123 3.0* 15.5–9.5
aHU1 0.37* 124 2.2* 16.4–12.0
rHU3 0.46* 123 0.03 0.54–0.50
rHU1 0.15 116 0.00 0.95–0.93
Accuracy Expert observers (n=263) aHU 0.84* 259 −1.0* 7.8–9.8
rHU 0.69* 252 −0.03* 0.10–0.73
ICC intraclass correlation coefficient, LoA limit of agreement, aHU absolute thrombus density in Hounsfield unit, rHU relative thrombus density
*p value <.05
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We have shown that trained non-expert observers have
an interobserver agreement similar to expert observers, and
a good agreement with expert observer measurements.
However, the detection of small occlusions was sometimes
more challenging for them and a few of these were missed.
Our study indicates a good correlation between three ROIs
and one ROI density measurements. However, overall, in-
terobserver agreement was lower when using one ROI
compared to three ROIs. Thrombi are generally heteroge-
neous in composition [16]; therefore, a single ROI assess-
ment samples only a limited region within the thrombus
compared to multiple ROIs, rendering the measured aHU
and rHU density more sensitive to the specific location of
the ROI in the thrombus (i.e., sampling bias). High user
variability in measurements may result in a limited repro-
ducibility and contribute to differences in found associa-
tions, such as that found in studies assessing the associa-
tion of thrombus density with patient outcome [5, 6, 10,
11].
This study has a number of limitations. There was a
large difference in the interobserver agreement between
different observer pairs. Despite the training session, two
expert observers routinely selected locations in the throm-
bus with higher signal intensities than the third expert ob-
server, which resulted in a systematic bias. Thin-slice
(≤2.5 mm) NCCT and CTA data were available only for
170 out of 388 patients. Because the trial from which the
data were collected was still ongoing, the full dataset was
not available at the time of this study. Because the data
were coming from a large number of medical centers, im-
aging parameters such as reconstruction parameters and
slice thickness varied considerably. However, since our
observers annotated the same images, it is not expected
that these variations have a large influence on the interob-
server agreement. This study is limited by the absence of a
reference standard for the actual histological thrombus
characteristics. As such, the accuracy of the density mea-
surements could not be determined. Furthermore, we also
could not address the difference in timing because all ob-
servers performed the full measurement by placement of
six markers. The interobserver variation of NCCT mea-
surements was performed with the support of simultaneous
viewing of CTA images. This is not routine in acute care or
radiological clinical practice. However, for thrombus den-
sity measurement in clinical studies, which is by far the
most common application of thrombus density measure-
ments, the support of CTA is performed in most studies;
CTA has been used as guidance for the presence and loca-
tion assessment of the clot location [5, 9, 10], has been
used as simultaneous visual support while performing the
NCCT density measurement [3, 4, 11], and has been used
for the assessment of the clot burden after an affine regis-
tration of CTA and NCCT images [12]. The visual support
of CTA may result in an increase in interobserver agree-
ment, since placement of annotations in low-density
thrombi in NCCT is considered difficult. Finally, we have
used the middle of the three ROIs was used as the single
ROI. This may have resulted in an overestimation of the
actual agreement compared to an evaluation in which the
single ROI measurement would have been performed
separately.
With an increasing number of available treatment op-
tions, precise characterization of the target thrombus is
required to enable optimal treatment selection [17]. Multi-
ple factors for treatment efficacy prediction are currently
investigated, including thrombus location [18], thrombus
length [19], enhancement in thrombus [20], collaterals sta-
tus [21], and thrombus density. Nevertheless, all possess
only limited associations, for example, recent research
showed that thrombus length measured on NCCT
(>8 mm) is a potential predictor of intra-venous treatment
failure [3]. However, commonly smaller thrombi do not
dissolve after intra-venous treatment administration. Inves-
tigating and improving understanding of the thrombus
composition will provide additional information to support
optimized treatment decision. In this process, estimations
of measurement accuracy and reproducibility are mandato-
ry. This study has contributed in thrombus measurement
accuracy estimations by assessing the interobserver agree-
ment for different measurement methods.
Conclusions
Our study reveals that the interobserver agreement for abso-
lute density measurement is superior to relative density mea-
surement. The use of multiple regions of interest when
assessing density provides a more reliable measurement com-
pared to single sample measurements. Absolute thrombus
density can reliably be measured even by non-expert ob-
servers using multiple ROIs; however, a few patients with
small indistinct thrombi would require support from experts.
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